Already registered for the BMS management of the Menopause Certificate e-Learning? Login in to BMS My Learning using your BMS My Learning username/email and password.

The BMS Management of the Menopause Certificate is a complete online education package that enables eligible healthcare professionals to develop the confidence needed to deal with 95% of patients who walk through their door, leaving only the 5% of complex cases to be referred for specialist menopause care.

This evidence-based menopause education, developed by healthcare professionals for healthcare professionals, is peer reviewed and incorporates recommendations for best practice from both national and international guidelines.

Watch our short video to get a flavour of the new Management of the Menopause Certificate online education:

Expand the sections below to learn more about the BMS Management of the Menopause Certificate and find out how this online education package will equip you to be the go-to person in your practice or service for gold-standard menopause care.

The Management of the Menopause Certificate comprises six interactive learning modules:

  • Assessment of women presenting with menopausal symptoms
  • HRT practical prescribing
  • Premature ovarian insufficiency (POI)
  • Menopause and HRT – health effects, benefits and risks
  • Breast cancer
  • Abnormal bleeding in perimenopause and postmenopause and unscheduled bleeding on HRT

The education is accessed via a dynamic learning management system and each module will deliver evidence-based, peer reviewed content using various different interactive media (e.g. videos, pop-up quizzes).  At the end of each module, there is formal knowledge assessment via multiple choice questions and learners must achieve the required pass mark to move onto the next module.

Interactive webinars, providing an opportunity to ask questions and clarify learning, will be offered.  Learners will be able to register for these optional sessions separately, once they have commenced the online education.

Download course structure

Module 1:  Assessment of women presenting with menopausal symptoms

  • vasomotor symptoms, incidence and aetiology
  • mood disorders
  • cognitive symptoms including impaired memory and concentration
  • insomnia and sleep disturbances
  • lack of energy and fatigue
  • connective tissue effects including skin and hair
  • genitourinary symptoms of the menopause (effect on female urethra, bladder, vagina and pelvic floor muscles)
  • sexual changes & sexual dysfunction
  • sexual health, including contraception, fertility advice and psychosexual counselling

Module 2: HRT practical prescribing

  • the place of estrogen, progestogen and testosterone in managing menopausal symptoms
  • the routes of delivery for medication and circumstances when these are indicated
  • types of HRT available and different combinations
  • side effects associated with estrogen, progestogen and testosterone intake
  • contraindications, risks and adverse effects of different preparations
  • the role of conventional and complementary therapies
  • the importance of lifestyle modifications

Module 3: Premature ovarian insufficiency (POI)

  • the physiology, epidemiology and demography of the climacteric, to include:
    • endocrine changes
    • aetiology, diagnosis and investigation of ovarian insufficiency
    • primary and secondary ovarian failure and surgical menopause
  • the role of anti-müllerian hormone (AMH) in assessing ovarian reserve and its potential role in the assessment of women with POI where the diagnosis is inconclusive
  • genetics of the menopause and the role of genetic screening and auto-antibody screening in women with POI
  • the differences between HRT and combined hormonal contraceptives (CHC), as well as the difference between CHC containing ethinyl estradiol and CHC preparations containing estradiol
  • the fertility implications of POI and the options available to women with POI seeking a pregnancy, including the role of egg donation
  • the role, pros and cons of fertility preservation and oocyte freezing in women at risk of POI
  • the role of HRT in preventing and treating low bone density in women with POI
  • limitations and reservations regarding the use of bisphosphonates in women with POI

Module 4: Menopause and HRT – health effects, benefits and risks

  • osteoporosis: assessing contributing factors and risk, including fracture risk assessment, active bone-protecting strategies, and treatments
  • the predisposing factors for cardiovascular risk and the effect of HRT on cardiovascular disease
  • cognition: effect of hormonal changes and dementia risk
  • the effects of hormones on the central nervous system, including migraine and epilepsy
  • the effects of hormones on other conditions including:
    • gastrointestinal disease, e.g. disorders of the gall bladder and liver
    • endocrine, e.g. diabetes and thyroid disease
    • autoimmune disease, e.g. rheumatoid arthritis, systemic lupus erythematosus
  • human immunodeficiency virus (HIV)

Module 5: Breast cancer

  • non-modifiable and lifestyle risk factors for breast cancer
  • HRT in women with benign breast conditions and the different levels of risk in these groups
  • principles of the NHS breast screening programme and the indications for imaging in symptomatic women
  • referral guidelines for women with breast symptoms and diagnostic triple assessment
  • principles of adjuvant endocrine therapy for breast cancer and chemoprevention in women at high risk of breast cancer in order to advise patients appropriately
  • the risks of treatment and non-treatment

Module 6: Abnormal bleeding in perimenopause and postmenopause and unscheduled bleeding on HRT

  • the causes of abnormal uterine bleeding in perimenopausal and postmenopausal women and those of unscheduled bleeding in women on HRT, and the principles of assessment in such cases
  • the difference between sequential and continuous combined HRT regimens and the bleeding patterns expected with both
  • the management options for women with unscheduled bleeding on HRT including modifications of their progestogen intake, including changing dose, duration of intake or the progestogen preparation used within the HRT regimen

Download Learning Objectives (PDF)

The Certificate is open to eligible registered HCPs (dietitians, doctors, nurses, pharmacists, physiotherapists, physician associates and paramedics) practising in the UK or Ireland only.

Learners will be required to confirm their professional registration when they register.  We currently recognise the following regulatory bodies:

  • General Medical Council (UK)
  • Irish Medical Council
  • Nursing & Midwifery Council (UK)
  • Nursing & Midwifery Board of Ireland
  • General Pharmaceutical Council (GB)
  • Pharmaceutical Society of Northern Ireland
  • Pharmaceutical Society of Ireland
  • Physician Associate Managed Voluntary Register (UK)
  • Health and Care Professions Council (UK)
  • Health and Social Care Professionals Council – CORU (Ireland)

There is approximately 38 hours of learning across the six learning modules.

Learners will have 12 months from the date of purchase to complete all the learning at their own pace. This allows plenty of time to review all the content and complete the knowledge assessments to achieve certification.

Assessment will take the form of multiple-choice questions at the end of each module. All learners must achieve a pass mark of 80% in the formal knowledge assessment for each of the six learning modules.

There is a fee of £975 to register for the Management of the Menopause Certificate. The Certificate comprises approximately five days of education, so this is the equivalent of £195 per day of learning.

A discount of £100 is available for eligible HCP BMS members.

A discount of £525 is available for learners who have completed a BMS PPMC course or the RCOG/BMS Post Reproductive Health meeting up to the end of 2023, to reflect an overlap in content and education already received.

Please note: all learners will be required to complete all six learning modules. This will provide an opportunity to reinforce any past learning and ensure that all learners are fully prepared for the formal knowledge assessments.

To receive a unique discount code please complete the discount request form.

The BMS Management of the Menopause Certificate is a BMS qualification. On completion of the online learning, learners will be issued with a certificate confirming that they have been provided with the knowledge to deliver BMS gold-standard, evidence-based menopause care. The Certificate will list each of the modules and their learning objectives, to demonstrate the in-depth, comprehensive nature of the education.

Please note: Completion of the online learning leads to a BMS qualification and CPD points/hours are not offered.

The Management of the Menopause Certificate online education is delivered via the BMS learning management system.  Learners are responsible for ensuring that the device they use to access the education meets the system requirements.

For full details of device compatibility and browser requirements, please go to https://totara.help/18/docs/end-user-system-requirements

Click on the links below to learn more about the BMS Management of the Menopause Certificate and find out how this online education package will equip you to be the go-to person in your practice or service for gold-standard menopause care.

By clicking on the button above, you will be redirected to the BMS e-commerce site to complete your purchase. You will be required to create a new account on this site with a new username and password (this is separate to an account for the members’ area of the BMS website).

Overview

The Management of the Menopause Certificate comprises six interactive learning modules:

  • Assessment of women presenting with menopausal symptoms
  • HRT practical prescribing
  • Premature ovarian insufficiency (POI)
  • Menopause and HRT – health effects, benefits and risks
  • Breast cancer
  • Abnormal bleeding in perimenopause and postmenopause and unscheduled bleeding on HRT

View the Course Structure (PDF)

The education is accessed via a dynamic learning management system and each module will deliver evidence-based, peer reviewed content using various different interactive media (e.g. videos, pop-up quizzes).  At the end of each module, there is formal knowledge assessment via multiple choice questions and learners must achieve the required pass mark to move onto the next module.

Interactive webinars, providing an opportunity to ask questions and clarify learning, will be offered.  Learners will be able to register for these optional sessions separately, once they have commenced the online education.

Back to contents list

Learning objectives

Module 1:  Assessment of women presenting with menopausal symptoms

  • vasomotor symptoms, incidence and aetiology
  • mood disorders
  • cognitive symptoms including impaired memory and concentration
  • insomnia and sleep disturbances
  • lack of energy and fatigue
  • connective tissue effects including skin and hair
  • genitourinary symptoms of the menopause (effect on female urethra, bladder, vagina and pelvic floor muscles)
  • sexual changes & sexual dysfunction
  • sexual health, including contraception, fertility advice and psychosexual counselling

Module 2: HRT practical prescribing

  • the place of estrogen, progestogen and testosterone in managing menopausal symptoms
  • the routes of delivery for medication and circumstances when these are indicated
  • types of HRT available and different combinations
  • side effects associated with estrogen, progestogen and testosterone intake
  • contraindications, risks and adverse effects of different preparations
  • the role of conventional and complementary therapies
  • the importance of lifestyle modifications

Module 3: Premature ovarian insufficiency (POI)

  • the physiology, epidemiology and demography of the climacteric, to include:
    • endocrine changes
    • aetiology, diagnosis and investigation of ovarian insufficiency
    • primary and secondary ovarian failure and surgical menopause
  • the role of anti-müllerian hormone (AMH) in assessing ovarian reserve and its potential role in the assessment of women with POI where the diagnosis is inconclusive
  • genetics of the menopause and the role of genetic screening and auto-antibody screening in women with POI
  • the differences between HRT and combined hormonal contraceptives (CHC), as well as the difference between CHC containing ethinyl estradiol and CHC preparations containing estradiol
  • the fertility implications of POI and the options available to women with POI seeking a pregnancy, including the role of egg donation
  • the role, pros and cons of fertility preservation and oocyte freezing in women at risk of POI
  • the role of HRT in preventing and treating low bone density in women with POI
  • limitations and reservations regarding the use of bisphosphonates in women with POI

Module 4: Menopause and HRT – health effects, benefits and risks

  • osteoporosis: assessing contributing factors and risk, including fracture risk assessment, active bone-protecting strategies, and treatments
  • the predisposing factors for cardiovascular risk and the effect of HRT on cardiovascular disease
  • cognition: effect of hormonal changes and dementia risk
  • the effects of hormones on the central nervous system, including migraine and epilepsy
  • the effects of hormones on other conditions including:
    • gastrointestinal disease, e.g. disorders of the gall bladder and liver
    • endocrine, e.g. diabetes and thyroid disease
    • autoimmune disease, e.g. rheumatoid arthritis, systemic lupus erythematosus
  • human immunodeficiency virus (HIV)

Module 5: Breast cancer

  • non-modifiable and lifestyle risk factors for breast cancer
  • HRT in women with benign breast conditions and the different levels of risk in these groups
  • principles of the NHS breast screening programme and the indications for imaging in symptomatic women
  • referral guidelines for women with breast symptoms and diagnostic triple assessment
  • principles of adjuvant endocrine therapy for breast cancer and chemoprevention in women at high risk of breast cancer in order to advise patients appropriately
  • the risks of treatment and non-treatment

Module 6: Abnormal bleeding in perimenopause and postmenopause and unscheduled bleeding on HRT

  • the causes of abnormal uterine bleeding in perimenopausal and postmenopausal women and those of unscheduled bleeding in women on HRT, and the principles of assessment in such cases
  • the difference between sequential and continuous combined HRT regimens and the bleeding patterns expected with both
  • the management options for women with unscheduled bleeding on HRT including modifications of their progestogen intake, including changing dose, duration of intake or the progestogen preparation used within the HRT regimen

Download Learning Objectives (PDF)

Back to contents list

Who can register?

The Certificate is open to registered HCPs (doctors, nurses, pharmacists, physiotherapists, physician associates and paramedics) practising in the UK or Ireland only.

Learners will be required to confirm their professional registration when they register.  We currently recognise the following regulatory bodies:

  • General Medical Council (UK)
  • Irish Medical Council
  • Nursing & Midwifery Council (UK)
  • Nursing & Midwifery Board of Ireland
  • General Pharmaceutical Council (GB)
  • Pharmaceutical Society of Northern Ireland
  • Pharmaceutical Society of Ireland
  • Physician Associate Managed Voluntary Register (UK)
  • Health and Care Professions Council (UK)
  • Physiotherapists Registration Board at CORU (Ireland)
Back to contents list

How long will it take to complete?

There is approximately 38 hours of learning across the six learning modules.

Learners will have 12 months from the date of purchase to complete all the learning at their own pace. This allows plenty of time to review all the content and complete the knowledge assessments to achieve certification.

Back to contents list

How is the Certificate assessed?

Assessment will take the form of multiple-choice questions at the end of each module. All learners must achieve a pass mark of 80% in the formal knowledge assessment for each of the six learning modules.

Back to contents list

How much does the Certificate cost?

There is a fee of £975 to register for the Management of the Menopause Certificate. The Certificate comprises approximately five days of education, so this is the equivalent of £195 per day of learning.

A discount of £100 is available for eligible HCP BMS members.

A discount of £525 is available for learners who have completed a BMS PPMC course or the RCOG/BMS Post Reproductive Health meeting up to the end of 2023, to reflect an overlap in content and education already received.

Please note: all learners will be required to complete all six learning modules. This will provide an opportunity to reinforce any past learning and ensure that all learners are fully prepared for the formal knowledge assessments.

To receive a unique discount code please complete the discount request form.

Back to contents list

What does the Certificate offer HCP learners?

The BMS Management of the Menopause Certificate is a BMS qualification. On completion of the online learning, learners will be issued with a certificate confirming that they have been provided with the knowledge to deliver BMS gold-standard, evidence-based menopause care. The Certificate will list each of the modules and their learning objectives, to demonstrate the in-depth, comprehensive nature of the education.

Please note: Completion of the online learning leads to a BMS qualification and CPD points/hours are not offered.

Back to contents list

System requirements

The Management of the Menopause Certificate online education is delivered via the BMS learning management system.  Learners are responsible for ensuring that the device they use to access the education meets the system requirements.

For full details of device compatibility and browser requirements, please go to https://totara.help/18/docs/end-user-system-requirements

Back to contents list

By clicking on the button above, you will be redirected to the BMS e-commerce site to complete your purchase. You will be required to create a new account on this site with a new username and password (this is separate to an account for the members’ area of the BMS website).